We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Large Trial To Investigate Repurposed Drugs To Treat Mild-to-Moderate COVID-19

News   Apr 20, 2021 | Original story from the National Institutes of Health

 
Large Trial To Investigate Repurposed Drugs To Treat Mild-to-Moderate COVID-19
 
 
Advertisement
 

RELATED ARTICLES

Enhanced Immune Control Found in Rare Few Who Can Naturally Manage HIV

News

Scientists have shown that elite controllers, a rare subset of people whose immune system can control HIV without the use of drugs, have myeloid dendritic cells, part of the innate immune response, that display traits of a trained innate immune cell.

READ MORE

Enzyme That Is Critical for Kidney Health Could Help 700 Million People Worldwide

News

University of South Australia researchers have identified an enzyme that may help to curb chronic kidney disease, which affects approximately 700 million people worldwide.

READ MORE

A Personalized Treatment Approach To Tackle Drug Resistance in Leukemia Patients

News

Researchers have identified a combination treatment that could potentially benefit T-ALL patients that do not respond to standard chemotherapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE